News

NexPoint Real Estate Finance Declares New Quarterly Dividend

NexPoint Real Estate Finance Declares New Quarterly Dividend

NexPoint Real Estate Finance Announces Quarterly Dividend

NexPoint Real Estate Finance, Inc. (NREF) has recently declared a quarterly regular dividend of $0.50 per share for its common stock. This decision was made during a meeting of the board of directors, reflecting the company’s ongoing commitment to delivering value to its shareholders.

Dividend Payment Details

The announced dividend is scheduled to be payable on December 31, 2024, to those stockholders who are on record by December 13, 2024. This timely update on dividend payments affirms NREF's strategies in maintaining strong cash flow while rewarding its dedicated shareholders.

Understanding NexPoint Real Estate Finance

NexPoint Real Estate Finance, Inc. operates as a publicly traded Real Estate Investment Trust (REIT). It primarily focuses on originating, structuring, and investing in a variety of mortgage loans. These include first-lien mortgage loans, mezzanine loans, and preferred equity, including other financial instruments that relate to real estate.

Investment Strategy and Portfolio

The company's investment strategies encompass multifamily properties and single-family commercial mortgage-backed securities and securitizations. As a big player in these sectors, NexPoint aims to provide competitive returns to its investors, tailoring its portfolio to meet the evolving needs of the real estate market.

About the Company

NexPoint Real Estate Finance, Inc.’s common stock and Series A Preferred Stock are traded under the symbols "NREF" and "NREF PRA" on the New York Stock Exchange. With a focus on proactive management of its investments, the company is poised to adapt to market changes while pursuing growth opportunities.

Corporate Communication Contacts

For investors seeking more information, Kristen (Thomas) Griffith leads the Investor Relations team and can be contacted directly through the email IR@nexpoint.com. The company emphasizes transparency and open communication with its stakeholders.

Continuing Growth Prospects

NexPoint is continually exploring avenues for growth and expansion in its investment portfolio. Through strategic planning and innovative financial solutions, it aims to enhance its market position, providing both stability and opportunities for its investors.

Frequently Asked Questions

What is NexPoint Real Estate Finance?

NexPoint Real Estate Finance, Inc. is a publicly traded REIT focused on real estate finance, specifically mortgage loans and equity investments.

When is the next dividend payment?

The next quarterly dividend payment is scheduled for December 31, 2024, for shareholders of record as of December 13, 2024.

What symbols does NexPoint trade under?

NexPoint's common stock trades under the symbol 'NREF,' while its Series A Preferred Stock trades under 'NREF PRA' on the NYSE.

How does NexPoint generate returns for its investors?

NexPoint generates returns through a diversified portfolio that includes securities backed by real estate, first-lien mortgage loans, and investment in multifamily properties.

Who can I contact for investor relations inquiries?

Investors can contact Kristen (Thomas) Griffith at IR@nexpoint.com for any inquiries related to investor relations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 7

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 2

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 4

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 2

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Season Highlights: Constellation, Delta, and Walgreens

Updated Category News Views 182

Earnings Season Highlights: Key Companies Preparing to Report The financial markets are buzzing as earnings season continues. This is an exciting time for investors and analysts alike as companies unveil their financial performance. On the horizon are a few major players that are set to announce their earnings. Notably, Constellation Brands (NYSE: STZ), Delta Air Lines...

Continue Reading
Mitek Plans Conference Call for Fiscal First Quarter Results

Updated Category News Views 98

Mitek Plans Conference Call for Fiscal First Quarter Results Mitek Systems, Inc. (NASDAQ: MITK), a leading player in digital identity verification and mobile capture technologies, is set to announce its financial results for the first quarter of the fiscal year. The financial information will be publicly released on an upcoming Monday, shortly before a conference call...

Continue Reading
ABN AMRO and Blackstone Forge Strategic Risk Transfer Deal

Updated Category News Views 191

ABN AMRO and Blackstone Collaborate on Risk Management In a notable development in the financial sector, ABN AMRO has successfully executed a significant risk transfer (SRT) transaction with funds managed by Blackstone. This strategic collaboration aims to enhance ABN AMRO's growth potential while effectively managing substantial corporate loan portfolios. The...

Continue Reading
Analyzing Williams Companies: P/E Insights and Implications

Updated Category News Views 113

Understanding the P/E Ratio of Williams Companies Currently, the stock of Williams Companies Inc. is trading at $59.89, reflecting a 0.40% increase in its price. Over the past month, the stock has surged by 15.07%, and in the past year, it has shown impressive growth of 64.19%. Such substantial performance has left long-term shareholders feeling quite optimistic. However,...

Continue Reading
Miami International Holdings Set to Launch Futures Trading Soon

Updated Category News Views 242

Miami International Holdings Plans Financial Futures Launch Miami International Holdings, Inc. (NYSE: MIAX) is gearing up to enhance its trading platform with the introduction of financial futures on MIAX Futures™. This strategic move marks a significant milestone for the company and is anticipated to offer traders new and exciting opportunities. Overview of MIAX...

Continue Reading